Antonella C.
- Country
- Italy
- Department
- Dipartimento Neuroscienze Umane - UOC di Neurologia
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Teriflunomide in Adults with Relapsing Multiple Sclerosis
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Increased Ocrelizumab Dose in Adults with Relapsing Multiple Sclerosis: A Phase IIIb Randomized Controlled Trial
Data & Insights
Has run more than one trial at 122 of 304 partner sites.
Specializations
Multiple Sclerosis Research
This investigator specializes in studying various therapeutic approaches for relapsing forms of multiple sclerosis, with particular emphasis on novel treatment modalities and their effects on disease progression.
- Relapsing Multiple Sclerosis (RMS)
- Secondary Progressive Multiple Sclerosis
- CNS Inflammation Management
The investigator examines innovative therapeutic combinations for managing neurological inflammation and disease progression.
Therapeutic Innovation
The investigator focuses on evaluating emerging therapeutic compounds and their comparative effectiveness in treating multiple sclerosis, including both monotherapy and combination approaches.
- Novel Drug Development
- Combination Therapy Assessment
- Treatment Optimization Studies
Research activities include investigation of dosing strategies and therapeutic efficacy in neurological conditions.
Clinical Outcomes
The investigator's work encompasses evaluation of disability progression and treatment response in multiple sclerosis patients through advanced imaging and clinical assessment methods.
- Disease Progression Monitoring
- MRI-Based Assessment
- Treatment Safety Evaluation
Research includes comprehensive analysis of therapeutic safety profiles and efficacy measures in neurological disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.